Prokaryotic expression and one-step purification of soluble diphtheria toxin variant CRM197
- VernacularTitle:原核表达及一步法制备可溶性白喉毒素突变体CRM197
- Author:
Yu-Hui GAO
1
;
Wei-Wei DENG
Author Information
1. 中国医学科学院基础医学研究所 北京协和医学院基础学院 病原学系
- Keywords:
diphtheria toxin mutant;
soluble expression;
autocleavage;
purification
- From:
Basic & Clinical Medicine
2018;38(6):815-820
- CountryChina
- Language:Chinese
-
Abstract:
Objective To construct a novel prokaryotic expression system, in which cross-reacting material 197 (CRM197) can be expressed in a soluble form in Escherichia coli(E. coli) cytoplasm and purified simply by one-step Ni-NTA affinity purification. Methods The CRM197 coding sequence was cloned into the prokaryotic expres-sion vector pET-32a(+) as an fusion protein with Trx tag,the HRV3C(human rhinovirus 3C) protease recognition sequence and 6 histidine sequence were added to the N-terminal of CRM197.HRV3C protease gene was cloned into another prokaryotic expression plasmid pGArasd. Both plasmids were co-transformed into E. coli Origami B (DE3) and induced mildly at 15℃. CRM197 recombinant protein was purified by Ni-NTA affinity matrix. Results The free soluble His-tagged CRM197 protein was released by cleavage of the accompanying expressed HRV3C protease after the CRM197 fusion protein was expressed. After one-step affinity purification recombinant CRM197 protein with a purity of almost 95% was obtained. Outcoming of the final preparation incubated with DNA indicated the pu-rified CRM197 recombinant protein has deoxyribonuclease activity. Conclusions By constructing a novel double-plasmid auto-cleavage prokaryotic expression system in this study, the production process of obtaining soluble CRM197 recombinant protein in E. coli has been simplified,with expression and purification efficiency improved and the production cost reduced.
